NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-006 Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Independent Clinical Trial Not Allowed)
Notice Number:
NOT-HL-21-013

Key Dates

Release Date:

May 12, 2021

Related Announcements

RFA-HL-20-006 - Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Independent Clinical Trial Not Allowed)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute of Allergy and Infectious Diseases (NIAID)

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that a set of responses to Frequently Asked Questions (FAQs) regarding RFA-HL-20-006 Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Independent Clinical Trial Not Allowed) has been posted at the following link: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/RFA-HL-20-006.


Applicants are strongly encouraged to review the FAQs, which may be updated at any time without additional notice, prior to submitting their application.

Inquiries

Please direct all inquiries to:

David Schopfer, M.D.
National Heart Lung and Blood Institute (NHLBI)
Telephone: 301-402-3833
Email:  David.schopfer@nih.gov

Qing Lu, DVM, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Phone: 301-480-9158
Email: qing.lu@nih.gov

Mark Damico, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5630
Email: mark.damico@nih.gov

Roya Kalantari, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-594-5945
Email:  roya.kalantari@nih.gov

Basil Eldadah, M.D., Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-6761
Email: basil.eldadah@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices